The FDA approved the medication more than six months ahead of schedule after trials showed it nearly doubled median survival ...
Although an inspiration for science fiction movies, gene therapy is real. Here is how it works and what could be improved ...
Nuvectis Pharma, Inc. announced that NXP200 (HSK42360), an oral, brain-penetrant, paradox-breaker BRAF inhibitor, has been g (BTD) for the treatment of patients with BRAF V600-mutant, recurrent or ...
Data from IDeate-Lung01 trial will be presented at upcoming IASLC 2025 World Conference on Lung Cancer First Breakthrough Therapy Designation for Daiichi Sankyo and Merck’s ifinatamab deruxtecan based ...
A New Drug Application is expected to be submitted to the FDA in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to zilganersen for the ...
NEW YORK, February 26, 2026--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare ...
The FDA has granted Breakthrough Therapy designation to GLM101 for phosphomannomutase 2 congenital disorder of glycosylation.
Please provide your email address to receive an email when new articles are posted on . Raludotatug deruxtecan has received breakthrough therapy designation for treatment of certain adults with ...
Add Yahoo as a preferred source to see more of our stories on Google. The latest FDA recognition is supported by positive results from several studies Novartis has announced that the US Food and Drug ...
Everyday Health on MSN
Is your SCIg therapy for PI working? How to spot breakthrough infections
SCIg helps people with certain types of primary immunodeficiency reduce their infection risk. But that doesn’t mean you won’t ...
Ipsen (IPSEY) (IPSEF) shares traded higher in Paris on Wednesday after the U.S. FDA issued Breakthrough Therapy Designation for its antibody therapy IPN60340 as a treatment for acute myeloid leukemia ...
Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results